Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: Insights from the AFFIRM and AF-CHF studies

European Journal of Heart Failure

Volumn 16, Issue 11, 2014, Pages 1168-1174

  Tremblay Gravel, Maxime ^a   Khairy, Paul ^a   Roy, Denis ^a   Leduc, Hugues ^a   Wyse, D George ^b   Cadrin Tourigny, Julia ^a   Macle, Laurent ^a   Dubuc, Marc ^a   Andrade, Jason ^a   Rivard, Lena ^a   Guerra, Peter G ^a   Thibault, Bernard ^a   Ahmed, Ali ^c   Talajic, Mario ^a   Guertin, Marie Claude ^a   White, Michel ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atrial fibrillation; Blood pressure; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; POST HOC ANALYSIS; SYSTOLIC BLOOD PRESSURE; ATRIAL FIBRILLATION; CAUSE OF DEATH; COMPLICATION; MORTALITY; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTOLE;

AGED; ATRIAL FIBRILLATION; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SYSTOLE;

EID: 84916606750     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.168     Document Type: Article

References (24)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R,. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
2. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK,. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
3. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D,. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000; 342: 1-8.
4. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ,. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006; 144: 884-893.
5. Lee TT, Chen J, Cohen DJ, Tsao L,. The association between blood pressure and mortality in patients with heart failure. Am Heart J 2006; 151: 76-83.
6. Ather S, Chan W, Chillar A, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Deswal A, Bozkurt B,. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J 2011; 161: 567-573.
7. Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A,. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol 2010; 106: 221-227.
8. White M, Desai RV, Guichard JL, Mujib M, Aban IB, Ahmed MI, Feller MA, de Denus S, Ahmed A,. Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST. Can J Cardiol 2012; 28: 354-359.
9. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S, American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007; 115: 2761-2788.
10. AFFIRM-Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
11. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677.
12. AFFIRM-Investigators. Atrial fibrillation follow-up investigation of rhythm management-the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators. Am J Cardiol 1997; 79: 1198-1202.
13. The AF-CHF Trial Investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002; 144: 597-607.
14. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ,. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
15. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P,. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001; 27: 85-95.
16. Rubin DB,. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons, Inc.; 1987.
17. Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP,. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 2009; 95: 56-62.
18. de Denus S, Lavoie J, Ducharme A, O'Meara E, Racine N, Sirois MG, Neagoe PE, Zhu L, Rouleau JL, White M,. Differences in biomarkers in patients with heart failure with a reduced versus a preserved left ventricular ejection fraction. Can J Cardiol 2012; 28: 62-68.
19. White M, Rouleau JL, Ruddy TD, De Marco T, Moher D, Chatterjee K,. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol 1991; 18: 1631-1637.
20. Mancia G, Fagard R, Narkiewicz K, Redõn J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219.
21. Tremblay-Gravel M, White M, Roy D, Leduc H, Wyse GD, Cadrin-Tourigny J, Macle L, Dubuc M, Andrade J, Rivard L, Guerra PG, Thibault B, Talajic M, Khairy P,. Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis. http://posterdocuments.com/posters/v/id/632; 2013.
22. Talajic M, Khairy P, Levesque S, Connolly SJ, Dorian P, Dubuc M, Guerra PG, Hohnloser SH, Lee KL, Macle L, Nattel S, Pedersen OD, Stevenson LW, Thibault B, Waldo AL, Wyse DG, Roy D, AF-CHF Investigators. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010; 55: 1796-1802.
23. Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ,. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol 2008; 52: 2000-2007.
24. Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, Fowler MB, Coats AJ, Castaigne A, Scherhag A, Holcslaw TL, Packer M, Carvedilol Prospective Randomised Cumulative Survival Study Group. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomised Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004; 43: 1423-1429.